Long-term anti-hypertensive therapy with benidipine improves arterial stiffness over blood pressure lowering

Toshihiro Kita1, Yoshihiko Suzuki, Tanenao Eto

  • 1The First Department of Internal Medicine, Miyazaki Medical School, 5200 Kihara, Kiyotake, 889-1692, Miyazaki, Japan. t-kita@po.sphere.ne.jp

Insights

Long-term benidipine treatment improves arterial stiffness beyond blood pressure reduction. This study establishes a method to evaluate drug effects on arterial properties, showing benidipine benefits arterial wall health.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Biomedical Engineering

Background:

  • Pulse wave velocity (PWV) measures arterial stiffness, a predictor of cardiovascular events.
  • Blood pressure (BP) influences PWV, complicating the assessment of anti-hypertensive drugs' effects on arterial properties.
  • Benidipine is an anti-hypertensive drug whose specific effects on arterial wall properties require clarification.

Purpose of the Study:

  • To establish a regression line between blood pressure (BP) and pulse wave velocity (PWV) changes.
  • To evaluate the long-term effect of benidipine on arterial properties using the derived regression line.
  • To determine if benidipine improves arterial wall properties independently of its BP-lowering effects.

Main Methods:

  • A short-term experiment involved administering nicardipine intravenously to 29 participants to establish the BP-PWV relationship.
  • A long-term study monitored BP and brachial-ankle PWV (baPWV) in 9 hypertensive patients treated with benidipine for 1 year.
  • BP and baPWV were re-evaluated after a 2-week suspension of benidipine to assess sustained effects.

Main Results:

  • The short-term experiment yielded a regression equation: deltaPWV (%) = 0.719 x deltaMBP (%), indicating PWV dependency on BP.
  • In long-term therapy, benidipine achieved stable BP control within 3 months, with actual PWV decreases (r-PWV) matching estimated decreases (e-PWV).
  • After 6 months, r-PWV exceeded e-PWV, suggesting benidipine improves arterial properties beyond BP reduction; these improvements persisted post-suspension.

Conclusions:

  • Long-term benidipine administration enhances arterial wall properties independently of blood pressure reduction.
  • The study provides a validated method to differentiate drug effects on BP versus direct arterial wall improvements.
  • Benidipine demonstrates a sustained positive impact on arterial stiffness, offering potential benefits for cardiovascular health.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...